Evidence map›Paper›PMID 32447801›Full record

ArticleDermatologic therapy2020

Herpes zoster might be an indicator for latent COVID 19 infection.

Mohamed L Elsaie, Eman A Youssef, Hesham A Nada

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatologic therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Association between COVID-19 infection and herpes zoster: A case series.Journal of family medicine and primary care · 2023
    Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Mohamed L ElsaieDepartment of Dermatology and Venereology, National Research Centre, Giza, Egypt.ORCID https://orcid.org/0000-0001-7541-5241
Eman A YoussefDepartment of Clinical Pathology, Cairo University, Giza, Egypt.
Hesham A NadaDepartment of Dermatology, Venereology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Cairo University · EGNational Research Centre · EGSuez Canal University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various cutaneous manifestations have been observed in patients with COVID-19 infection. Herpes zoster is a viral skin disease caused by varicella zoster that remains dormant in the dorsal root ganglia of cutaneous nerves following a primary chicken pox infection. In this report, we describe two cases COVID infection who first presented with herpes zoster. We are here by suggesting that the clinical presentation of HZ at the time of the current pandemic even in patients giving mild or no suggestive history of upper respiratory symptoms should be considered as an alarming sign for a recent subclinical SARS CoV2 infection.

Indexed as

AgedAntiviral AgentsBetacoronavirusClinical Laboratory TechniquesCoinfectionCoronavirus InfectionsCOVID-19COVID-19 TestingDiagnosis, DifferentialFemaleHerpes ZosterHumansMaleMiddle AgedPandemicsPneumonia, ViralAntiviral AgentsCOVID19Herpes zosterimmune suppressionSARS CoV2skin rash

Identifiers

PMID32447801
PMCPMC7267085
OpenAlexW3027981572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.